Thomas H Frazier

Summary

Affiliation: University of Louisville
Country: USA

Publications

  1. doi request reprint Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury
    Thomas H Frazier
    Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA
    JPEN J Parenter Enteral Nutr 35:14S-20S. 2011
  2. doi request reprint Pharmaconutrition for the obese, critically ill patient
    Ryan T Hurt
    Department of Medicine, University of Louisville School of Medicine, 550 South Jackson St, Louisville, KY 40202, USA
    JPEN J Parenter Enteral Nutr 35:60S-72S. 2011
  3. doi request reprint Nutrition therapy of the severely obese, critically ill patient: summation of conclusions and recommendations
    Stephen A McClave
    Department of Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA
    JPEN J Parenter Enteral Nutr 35:88S-96S. 2011
  4. ncbi request reprint Obesity, inflammation, and the potential application of pharmaconutrition
    Matt C Cave
    Department of Medicine, University of Louisville School of Medicine, 500 S Jackson Street, University of Louisville, Louisville, KY 40292, USA
    Nutr Clin Pract 23:16-34. 2008
  5. pmc Treatment of alcoholic liver disease
    Thomas H Frazier
    Department of Internal Medicine and Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, Louisville, KY, USA
    Therap Adv Gastroenterol 4:63-81. 2011

Detail Information

Publications5

  1. doi request reprint Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury
    Thomas H Frazier
    Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA
    JPEN J Parenter Enteral Nutr 35:14S-20S. 2011
    ..Here the authors review the role of the gut microbiota and metabolic endotoxemia-induced inflammation in the development of obesity and liver injury, with special reference to the intensive care unit setting...
  2. doi request reprint Pharmaconutrition for the obese, critically ill patient
    Ryan T Hurt
    Department of Medicine, University of Louisville School of Medicine, 550 South Jackson St, Louisville, KY 40202, USA
    JPEN J Parenter Enteral Nutr 35:60S-72S. 2011
    ..These nutrients could potentially be added to current EN formulas or provided as supplements...
  3. doi request reprint Nutrition therapy of the severely obese, critically ill patient: summation of conclusions and recommendations
    Stephen A McClave
    Department of Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA
    JPEN J Parenter Enteral Nutr 35:88S-96S. 2011
    ..The ideal enteral formula should have a low nonprotein calorie to nitrogen ratio and have a variety of pharmaconutrient agents added to modulate immune responses and reduce inflammation...
  4. ncbi request reprint Obesity, inflammation, and the potential application of pharmaconutrition
    Matt C Cave
    Department of Medicine, University of Louisville School of Medicine, 500 S Jackson Street, University of Louisville, Louisville, KY 40292, USA
    Nutr Clin Pract 23:16-34. 2008
    ..A number of dietary agents such as arginine, fish oil, and carnitine may correct these problems at the molecular level. Pharmaconutrition formulas may provide exciting innovations for the nutrition therapy of the obese patient...
  5. pmc Treatment of alcoholic liver disease
    Thomas H Frazier
    Department of Internal Medicine and Division of Gastroenterology, Hepatology and Nutrition, University of Louisville School of Medicine, Louisville, KY, USA
    Therap Adv Gastroenterol 4:63-81. 2011
    ..Transplantation is effective in patients with end-stage ALD who have stopped drinking (usually for ≥6 months), and both long-term graft and patient survival are excellent...